On the basis of these data, we proposed that EA upregulates SIRT1-PPARγ- PGC-1, which represses BACE1 expression, thereby reducing Aβ production and consequently improving cognitive deficits in an AD animal model. This evidence concerns the gene PPARGC1A and Alzheimer disease.